| PERIOD ENDING | 20-Sep-09 | 21-Jun-09 | 22-Mar-09 | 21-Dec-08 | | Total Revenue | 307,972 | 278,484 | 272,351 | 314,715 | | Cost of Revenue | 248,364 | 226,339 | 229,659 | 265,606 | | | Gross Profit | 59,608 | 52,145 | 42,692 | 49,109 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 23,857 | 27,887 | 27,768 | 28,195 | | Non Recurring | 1,981 | 20,872 | 788 | 28,659 | | Others | 14,814 | 14,592 | 14,955 | 15,312 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 18,956 | (11,206) | (819) | (23,057) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1) | (60) |
-
| 60 | | Earnings Before Interest And Taxes | 18,955 | (11,266) | (819) | (22,997) | | Interest Expense | 10,563 | 9,255 | 9,431 | 7,571 | | Income Before Tax | 8,392 | (20,521) | (10,250) | (30,568) | | Income Tax Expense | (45) | 10,561 | (297) | (11,773) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 8,437 | (31,082) | (9,953) | (18,795) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 8,437 | (31,082) | (9,953) | (18,795) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $8,437 | ($31,082) | ($9,953) | ($18,795) |
|
0.51% Nasdaq 
Income Statement
